Related Experiment Video
Updated: Jul 6, 2025

03:37
Iatrogenic Injury Recapitulated: Electroexcision Technique for Urethral Stricture Modeling in Rats
Published on: October 11, 2024
355
[Regnerative technologies in reconstructive operations on the urethra: a review. Part 2]
N Pavlov V1,2, A Kazikhinurov R1,2, A Kazikhinurov A1,2
1Federal State Budgetary Educational Institution of Higher Education Bashkir State Medical University of the Ministry of Health of the Russian Federation, Ufa, Russia.
Urologiia (Moscow, Russia : 1999)
|December 29, 2023
Summary
Regenerative medicine offers new hope for urethral stricture treatment, utilizing stromal vascular fraction (SVF) from adipose tissue and biomaterials. These advanced therapies aim to improve outcomes and reduce relapses in urethroplasty.
Area of Science:
- Regenerative medicine and tissue engineering applied to urology.
- Focus on advanced therapeutic strategies for urethral strictures.
Background:
- Urethral reconstruction presents challenges due to limited autologous tissue and high relapse rates.
- Need for alternative treatments in urethroplasty is critical for patient outcomes.
Approach:
- Review of current regenerative technologies, biomaterials, and cell therapy in urethroplasty.
- Exploration of stromal vascular fraction (SVF) from adipose tissue as a therapeutic agent.
- Analysis of cell-free and cellular biomaterials in experimental urethral reconstruction studies.
Key Points:
- Stromal vascular fraction (SVF) derived from autologous adipose tissue offers a promising cell source for urethral repair.
- Biomaterials, both cell-free and cellular, are being investigated for their role in urethral reconstruction.
- Tissue engineering provides innovative solutions to overcome limitations in current urethroplasty techniques.
Conclusions:
- The combination of SVF and biomatrix presents a potentially safe and effective therapeutic approach.
- These regenerative strategies may accelerate healing and significantly benefit patients with urethral diseases.
- Future research directions focus on optimizing SVF and biomaterial applications in clinical settings.

